Kepler Blog · pharma marketing

Pharma Teams: Side Effects Reported Everywhere but to You

Patients describe side effects online months before formal reporting. Learn how digital monitoring surfaces early signals and how to separate them from noise.

Published 8 September 2026 By Kepler Pharma MarketingPharmacovigilanceSocial Listening

The Report You Never Received

Patients describe side effects online long before anything reaches a formal reporting system. They post in groups, comment under videos, and ask questions in forums, using ordinary language rather than clinical terminology.

None of that reaches a medical team through official channels. A patient describing sleep disruption in a support group is not filing a report, and the pharmacist they mentioned it to in passing may not have filed one either.

That gap is not a compliance failure by anyone. It is simply a structural feature of how patients actually talk about their own experience.

The information already exists, it is entirely public, and it often runs months ahead of anything arriving through formal routes. What is missing is anyone looking at it systematically and knowing what to do with what they find.

In our work across the region, we consistently see patient conversation carrying early signals that formal channels only surface much later and usually in far smaller volume than the conversation itself.

Why Formal Reporting Lags

Formal reporting depends on a patient mentioning something, a professional recognizing it as reportable, and then someone completing the process properly. Each of those steps loses volume.

Most patients do not know a reporting system exists at all. Those who do rarely consider a mild or ambiguous experience worth reporting, so it ends up in a conversation with other patients instead of in a form.

That does not make the experience any less real or less relevant to a medical team. It means the earliest and largest body of patient-reported experience sits in public conversation rather than inside a database.

By the time volume appears through formal routes, the same pattern has usually been visible online for some time.

Signal Versus Noise

Not every complaint posted online is a safety signal. A single post describing an unrelated experience is simply noise, and treating it as anything more creates work without producing any insight.

What matters is the pattern: the same description recurring across unconnected patients, in similar terms, within a defined period of time. That repetition is the only thing separating a genuine signal from an isolated anecdote.

Building the Monitoring Layer

Digital monitoring does not replace formal pharmacovigilance. It runs alongside it, providing earlier visibility into what patients are experiencing and how they describe it.

Five rules make the difference between a monitoring layer that works and one that simply produces unusable volume every month.

  • Track the language patients use, not clinical terminology
  • Monitor forums and groups, not only open platforms
  • Watch for repetition across unconnected accounts
  • Define clear escalation criteria before monitoring begins
  • Document the review process for audit purposes

The escalation rules matter most of all. Without criteria agreed in advance, monitoring produces volume nobody is able to act on, and the whole exercise quietly stops within a quarter.

Where Kepler Comes In

Kepler's Online Pharmacovigilance is built specifically for this, structured to identify and route patient-reported experiences in line with regulatory expectations rather than as informal observation.

Social Media Advanced Listening covers where these conversations actually take place, including the closed groups and comment threads that standard monitoring tools do not reach at all.

Digital Market Intelligence & Research places those findings in market context, distinguishing a pattern specific to one product from a broader category conversation affecting every brand in it.

Acting on What You Find

Monitoring only creates real value when the medical team receives findings in a form they can assess quickly and then act on inside their existing processes without extra work.

Reporting should arrive summarized by pattern rather than as raw volume, with the underlying conversation still available for review whenever something warrants closer attention.

Medical content writing then addresses those recurring concerns directly, because a question appearing repeatedly in patient conversation is one worth answering clearly inside approved material.

Start by monitoring a single product for one full quarter. The volume and the nature of what surfaces will settle the question of whether this belongs permanently in the process.

The earliest patient reports are public, and nobody has to send them to you.

Share this article ← All posts

Let's Create Something Extraordinary

Let's Talk
KSA: +966 59 934 0264  ·  UAE: +971 50 500 2109